LENZ Therapeutics, Inc.
LENZCIK 0001815776 · Every Form 4 filed by insiders at this issuer.
Filings
4
Latest Mar 25, 2024
Unique insiders
8
Showing
4 of 4
Page 1
Top insiders
Most active reporters at LENZ Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Drapkin Kimberlee C | Director | 1 |
| Kolchinsky Peter | Director10% Owner | 1 |
| MCCOLLUM JAMES W | Director | 1 |
| RA CAPITAL MANAGEMENT, L.P. | Director10% Owner | 1 |
| RA Capital Healthcare Fund LP | Director10% Owner | 1 |
| RA Capital Nexus Fund II, L.P. | Director10% Owner | 1 |
| Shah Rajeev M. | Director10% Owner | 1 |
| Thunen Shelley B | Director | 1 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 25, 2024 | RA CAPITAL MANAGEMENT, L.P. Director · 10% Owner | P | 933,038 | $15.03 | $14,023,561 | |
| Mar 25, 2024 | Drapkin Kimberlee C Director | Holdings only | — | — | — | |
| Mar 25, 2024 | MCCOLLUM JAMES W Director | A | 16,633 | $15.0299 | $249,992 | |
| Mar 25, 2024 | Thunen Shelley B Director | Holdings only | — | — | — |
Showing 1–4 of 4
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.